| For: | Gligorijević N, Minić S, Nedić O. Structural changes of proteins in liver cirrhosis and consequential changes in their function. World J Gastroenterol 2022; 28(29): 3780-3792 [PMID: 36157540 DOI: 10.3748/wjg.v28.i29.3780] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i29/3780.htm |
| Number | Citing Articles |
| 1 |
A. A. Turkina, M. V. Maevskaya, M. S. Zharkova, V. T. Ivashkin. Changes in the Structural and Functional Albumin Properties in Patients with Decompensated Liver Cirrhosis. Russian Journal of Gastroenterology, Hepatology, Coloproctology 2023; 33(1): 40 doi: 10.22416/1382-4376-2023-33-1-40-50
|
| 2 |
Fuqiang Quan, Xiujuan Wang, Zhangfan Huang, Lumin Kong, Yi Lin, Hao Lin, Sishun Zhou, Jianrong Ma, Yanbo Zhao, Yunting Zhao, Longhui Liu, ZhongBao Li. The potential effects of inulin on lipid metabolism disorders in spotted sea bass (Lateolabrax maculatus) induced by a high-fat diet. Aquaculture 2025; 605: 742510 doi: 10.1016/j.aquaculture.2025.742510
|
| 3 |
László Orosz, Károly Péter Sárvári, Áron Dernovics, András Rosztóczy, Klára Megyeri. Pathogenesis and clinical features of severe hepatitis E virus infection. World Journal of Virology 2024; 13(2): 91580 doi: 10.5501/wjv.v13.i2.91580
|
| 4 |
Jakub Witkowski, Sibylle Neuhoff, Mailys De Sousa Mendes, Frederic Y. Bois, Matthew D. Harwood. Assessing Hepatic Impairment with Biomarker-informed Physiologically-based Pharmacokinetic Modelling (BI-PBPK): Strengths and Limitations of the Endogenous Biomarker Coproporphyrin-I. Drug Metabolism and Disposition 2025; : 100209 doi: 10.1016/j.dmd.2025.100209
|
| 5 |
Yueqing Han, Qi Gao, Yating Xu, Ke Chen, Rongxin Li, Weiran Guo, Shuzhen Wang. Cysteine sulfenylation contributes to liver fibrosis via the regulation of EphB2-mediated signaling. Cell Death & Disease 2024; 15(8) doi: 10.1038/s41419-024-06997-9
|
| 6 |
Seul Ki Han, Soon Koo Baik, Moon Young Kim. Protein and Macronutrient Metabolism in Liver Cirrhosis: About Sarcopenia. Nutrients 2025; 17(21): 3346 doi: 10.3390/nu17213346
|
| 7 |
Eleonora Forte, Jes M. Sanders, Indira Pla, Vijaya Lakshmi Kanchustambham, Michael A.R. Hollas, Che-Fan Huang, Aniel Sanchez, Katrina N. Peterson, Rafael D. Melani, Alexander Huang, Praneet Polineni, Julianna M. Doll, Zachary Dietch, Neil L. Kelleher, Daniela P. Ladner. Top-Down Proteomics Identifies Plasma Proteoform Signatures of Liver Cirrhosis Progression. Molecular & Cellular Proteomics 2024; 23(12): 100876 doi: 10.1016/j.mcpro.2024.100876
|
| 8 |
Shoichi Matsutani, Makoto Arakawa, Susumu Nakano. Effectiveness and safety of antithrombin for treatment of portal vein thrombosis: Nationwide prospective surveillance of 4 years of clinical experience in Japan. Hepatology Research 2025; 55(9): 1251 doi: 10.1111/hepr.14197
|
| 9 |
Chetan Naik. Assessment and Improvement of Patient Knowledge on Liver Cirrhosis Prevention Using Structured Teaching in a Hospital Setting. Nigerian Postgraduate Medical Journal 2025; 32(4): 405 doi: 10.4103/npmj.npmj_242_25
|
| 10 |
Karli R. LeFort, Wiramon Rungratanawanich, Byoung-Joon Song. Contributing roles of mitochondrial dysfunction and hepatocyte apoptosis in liver diseases through oxidative stress, post-translational modifications, inflammation, and intestinal barrier dysfunction. Cellular and Molecular Life Sciences 2024; 81(1) doi: 10.1007/s00018-023-05061-7
|
